Search results (168)
« Back to Latest newsVascular dementia clinical trial, LACI-Cog, seeks public views of plans
19 January 2026
A DPUK study testing new treatments for vascular cognitive impairment and vascular dementia, is looking for people to complete a survey about the study and their approach to the work.
Online survey to help tailor counselling for people taking APOE4 test
12 January 2026
Researchers at the University of Oxford and Imperial College London are looking for particpants to complete a 15-minute questionnaire to help develop appropriate counselling tools for people taking an APOE4 gene test. They want to make sure the information is clear, respectful, and relevant by gathering opinions and perspectives from a range of people with a close interest in or experience of dementia.
READ-OUT celebrates its first year by recruiting the 500th participant
6 January 2026
Alex McCreadie, a retired former soldier and health and safety professional, became the 500th participant in DPUK's #READ-OUT study. The study is evaluating the accuracy of tests diagnosing dementia to use in the NHS. He was recruited by ReMind UK in Bath, one of 21 sites already operating as part of the study. In 2026, 10 more locations will join the network, including sites as far north as Stornaway in the Outer Hebrides.
What next for GLP-1 receptor agonists and dementia?
9 December 2025
Novo Nordisk's EVOKE trial didn't meet its primary endpoint - semaglutide didn't slow cognitive decline in people with early Alzheimer's. But the results revealed something intriguing: reductions in biomarkers of neurodegeneration, inflammation, and tau protein. The drug does something to Alzheimer's biology - the question is when to use it.
Top partnership award for DPUK, Eli Lilly and NHS trusts biomarker collaboration
21 November 2025
Dementias Platform UK is delighted to announce that our biomarker pilot project, delivered in collaboration with Eli Lilly & Company, has won the prestigious HSJ Partnership of the Year Award 2025!
Access requests reach record high for Data Portal AND numbers double in last 5 years
27 October 2025
The growth in the number of studies using the DPUK Data Portal continues to grow. With two months of 2025 remaining, we have exceeded last year’s record number of access applications.
READ-OUT study is accelerating innovation in digital cognitive assessments for dementia
24 October 2025
DPUK is delighted to have received funding from Innovate UK through the Dame Barbara Windsor Dementia Goals programme to add a digital dimension to its READ-OUT study. Dementia is the UK's biggest killer and around a million people in the UK have a form of the disease. 1 in 3 of them never get a formal diagnosis. Early and accurate diagnosis is essential to identify those who may benefit from new treatments that can slow down Alzheimer’s disease.
READ-OUT celebrates a milestone as its 19th clinical site accepts participants for the Blood Biomarker Challenge study
8 October 2025
DPUK's READ-OUT study, part of the Blood Biomarker Challenge, has reached a major milestone with the commissioning of its 19th clinical site to the study. It now has half of its planned 30 sites operational, recruiting participants to the study.
Booking open for GREAT MINDS LIVE
9 September 2025
The latest in our long-running series of popular events for Great Minds members and others interested in dementia is taking place in Oxford on 16th October.
Times 2 features READ-OUT participants with declining cognition
20 August 2025
We're pleased to share Anna Maxted's thoughtful feature in The Times, published yesterday: "The dementia patients who could change lives". Her story captures the personal experiences of volunteers participating in the DPUK READ-OUT study, part of the Blood Biomarker Challenge. We're grateful to Beverley Evans and Stephanie Everill for generously sharing their stories with The Times. Their willingness to share their personal experiences helps us in reaching a wider audience to talk about the valuable research we are doing to bring blood biomarkers for dementia into common usage within the NHS.
Promising news about a 'next gen' drug and nexus of a global research network - AAIC25 take-aways
1 August 2025
It may have been 5 long days in Toronto for our DPUK delegation, but AAIC25 has been full of announcements, opportunities and insights. Whether you are in the early stages of your career or a relative veteran in dementia research, there has been plenty to take away and consider. I asked three of our DPUK team about what they are taking away from the conference.
Cost too high, benefit too small. No new drugs on the NHS
23 June 2025
The NHS will not be offering patients two new drugs that slow progression of Alzheimer’s Disease following a decision by the regulator, NICE. They have assessed that donanemab and lecanemab provide only a small benefit which does not justify the high cost to the health service.
Latest AI and synthetic data workshop in Birmingham
6 June 2025
DPUK’s Data Portal team is hosting the latest of a series of workshops about AI in research in collaboration with the UK Synthetic Data Community Group in Birmingham on 20th June. Registration is FREE and there is help available for the cost of travel.
Generating synthetic data using AI for neuroimaging - Webinar 29th May
28 May 2025
Seminar: Generating synthetic data using AI for neuroimaging DPUK has teamed up with the Deep Dementia Phenotyping (DEMON) Network to present a series of online webinars about applications and benefits of AI in dementia research. The first in the series was held on Thursday 29th May.
READ-OUT Study Progress: 8 UK Sites Now Open with More to Follow This Month
14 May 2025
DPUK's READ-OUT project has reached a notable milestone with eight sites now actively recruiting participants across the UK, and several more centres set to open by the end of the month. This steady expansion represents important progress in improving dementia diagnosis through blood biomarker research.
DPUK collaboration wins HSJ Partnership Award
26 March 2025
Congratulations to everyone in the project team, winners of the HSJ Award for the ‘Best Pharmaceutical Partnership with the NHS’. The project was described by the organisers as 'improving accurate, early diagnosis of Alzheimer’s Disease'.
Digital test is a boost to READ-OUT biomarker study into effective ways of spotting dementia sooner
25 March 2025
People could get the right help for the diseases that can cause dementia sooner following the announcement today of a £2 million injection of funding from the government to help spot these earlier.
Alzheimer’s Disease Biomarker Pilot Project launched at Oxford Health Clinical Research Facility
29 November 2024
A new service development project, run by Dementias Platform UK (DPUK) supported under a Collaborative Working Agreement by Eli Lilly and Company and Oxford Health NHS Foundation Trust has been launched at the Oxford Health Clinical Research Facility (OH CRF).
DPUK Research Reflections
7 November 2024
It's been ten years since Dementias Platform UK first launched back in the autumn of 2014. We hear from some of those who were there when it all started as they give their assessment of what's been accomplished.
A decade of DPUK research
4 November 2024
Dementias Platform UK is ten years old. We launched in 2014 and have over the decade built an infrastructure which has enabled wide-ranging research and brought together a collaborative community in dementia research. During the 2024 Clinical Trials on Alzheimer's Disease (CTAD) conference, Professor John Gallacher was reflecting on a decade of hard work by the large team past and present at DPUK.